Home
Explore services
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
Responsive Menu
Home
Explore services
▼
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
▼
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
▼
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
LOGIN
Research Insights
Predicting Price Erosion with Indication Expansion: A Deep Dive
1 February 2024
Read More
Harnessing the power of machine learning in market access & pricing
25 January 2024
Read More
Unlocking Pharma Dynamics: LoE Impact Analysis
5 January 2024
Read More
Predicting value and price of orphan drugs: a comparison across Europe and the US
5 January 2024
Read More
Pharmaceutical market access & pricing research: Key trends & industry developments
13 March 2023
Read More
How to unlock value for your orphan asset with GPI
15 February 2023
Read More
An assessment of the orphan drugs landscape for pharma manufacturers
30 January 2023
Read More
The state of international reference pricing in 2023: Canada and South Korea in the spotlight
6 January 2023
Read More
GPI demonstrates the strength of forecasting ability across market-specific value frameworks
By Kate Anstee
27 July 2022
Read More
Biomarker-targeted therapies: the answer to advancing equitable cancer care?
By Kate Anstee
1 June 2022
Read More
« Previous
1
2
3
Next »
Yearly Archives
2025
2024
2023
2022
2021
Stay Informed
Sign up to receive the latest news and trends
straight into your inbox from GPI